机译:通过嵌合受体增强疫苗,增强了针对实体瘤的C AR-T细胞活性
MIT, David H Koch Inst Integrat Canc Res, 77 Massachusetts Ave, Cambridge, MA 02139 USA|Howard Hughes Med Inst, Chevy Chase, MD 20815 USA;
MIT, David H Koch Inst Integrat Canc Res, 77 Massachusetts Ave, Cambridge, MA 02139 USA;
MIT, David H Koch Inst Integrat Canc Res, 77 Massachusetts Ave, Cambridge, MA 02139 USA;
MIT, David H Koch Inst Integrat Canc Res, 77 Massachusetts Ave, Cambridge, MA 02139 USA;
MIT, David H Koch Inst Integrat Canc Res, 77 Massachusetts Ave, Cambridge, MA 02139 USA;
MIT, David H Koch Inst Integrat Canc Res, 77 Massachusetts Ave, Cambridge, MA 02139 USA;
MIT, David H Koch Inst Integrat Canc Res, 77 Massachusetts Ave, Cambridge, MA 02139 USA;
MIT, David H Koch Inst Integrat Canc Res, 77 Massachusetts Ave, Cambridge, MA 02139 USA;
MIT, David H Koch Inst Integrat Canc Res, 77 Massachusetts Ave, Cambridge, MA 02139 USA;
MIT, David H Koch Inst Integrat Canc Res, 77 Massachusetts Ave, Cambridge, MA 02139 USA;
MIT, David H Koch Inst Integrat Canc Res, 77 Massachusetts Ave, Cambridge, MA 02139 USA;
MIT, David H Koch Inst Integrat Canc Res, 77 Massachusetts Ave, Cambridge, MA 02139 USA|MIT, Dept Biol Engn, 77 Massachusetts Ave, Cambridge, MA 02139 USA;
MIT, David H Koch Inst Integrat Canc Res, 77 Massachusetts Ave, Cambridge, MA 02139 USA;
MIT, David H Koch Inst Integrat Canc Res, 77 Massachusetts Ave, Cambridge, MA 02139 USA;
MIT, David H Koch Inst Integrat Canc Res, 77 Massachusetts Ave, Cambridge, MA 02139 USA;
MIT, David H Koch Inst Integrat Canc Res, 77 Massachusetts Ave, Cambridge, MA 02139 USA|MIT, Dept Biol Engn, 77 Massachusetts Ave, Cambridge, MA 02139 USA|MIT, Dept Chem Engn, Cambridge, MA 02139 USA;
MIT, David H Koch Inst Integrat Canc Res, 77 Massachusetts Ave, Cambridge, MA 02139 USA|Howard Hughes Med Inst, Chevy Chase, MD 20815 USA|MIT, Dept Biol Engn, 77 Massachusetts Ave, Cambridge, MA 02139 USA|MIT, Dept Mat Sci & Engn, Cambridge, MA 02139 USA|MIT, Ragon Inst, Massachusetts Gen Hosp, 77 Massachusetts Ave, Cambridge, MA 02139 USA;
机译:双特异性嵌合抗原受体T细胞和间接疫苗在免疫活性剂,自抗原设置中消除各种大型实体瘤
机译:鼠髓样来源的抑制细胞的中和作用增强了针对小儿实体瘤的嵌合抗原受体T细胞的功效
机译:通过合成双官能PD-L1阻断肽增强可切换双嵌合抗原受体工程T细胞的安全性和抗肿瘤效果。通过合成双官能PD-L1阻断肽
机译:患者临床试验与患有转移和/或复发性固体瘤的患者的HER-2 B细胞嵌合和多型肽疫苗
机译:优化嵌合抗原受体(汽车)T细胞通过IL-36γ进行增强和扩大的抗肿瘤免疫应答
机译:通过嵌合受体增强疫苗增强了针对实体瘤的CAR-T细胞活性
机译:4-1BB信号传导促进CD28掺入的第2代嵌合抗原受体改性T细胞的抗肿瘤活性